Orgenesis Reports Revenue Growth of 364% for 2021 and Provides Business Update
GERMANTOWN, Md., March 30, 2022 -- Orgenesis Inc. , a global biotech company working to unlock the full potential of cell and gene therapies, today reports its financial results for the year ended... | March 30, 2022